Weekly Recap: 14 Health Press Releases You Need to See

A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including Planet Fitness' High School Summer Pass™ and Oracle's partnership with Cleveland Clinic and G42.

NEW YORK, May 23, 2025 /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help healthcare journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories from the week that shouldn't be missed.

The list below includes the headline (with a link to the full text) and an excerpt from each story. Click on the press release headlines to access accompanying multimedia assets that are available for download.

1. Strength Starts Here: Planet Fitness' Annual High School Summer Pass™ Program Returns This June 
   "With free access to our clubs throughout the summer, we're providing teens with the tools they need to develop healthy fitness habits that can last a lifetime. We look forward to welcoming teens this summer to experience the mental and physical health benefits of exercise in the Judgement Free Zone^®," said Colleen Keating, Chief Executive Officer.
2. Oracle, Cleveland Clinic, and G42 Announce Strategic Partnership to Launch AI-Based Global Healthcare Delivery Platform 
   The platform will serve as the foundation for an AI-driven healthcare hub, combining Oracle Cloud Infrastructure, Oracle AI Data Platform, and Oracle Health applications, Cleveland Clinic's world-class clinical expertise, and G42's capabilities in sovereign AI infrastructure, health data integration, and advanced clinical AI models.
3. Apnimed Announces Positive Topline Results in the First Landmark Phase 3 Clinical Trial of AD109, an Investigational Once-daily Oral Pill for Obstructive Sleep Apnea
   "The positive results from our Phase 3 SynAIRgy trial bring us closer to realizing our vision of offering a simple, safe, and effective oral drug — one that is grounded in science, driven by unmet need, and centered on people with OSA. We believe these results represent the dawn of a new era in the OSA treatment paradigm," said Larry Miller, MD, Chief Executive Officer of Apnimed.
4. DuPont and Epicore Biosystems Collaborate to Advance Worker Safety Through Smart Wearable Technology 
   Epicore's Connected Hydration wearable solution provides real-time hydration and physiological tracking. In combination with DuPont's personal protective clothing, these biometric data streams and personalized recommendations have the potential to offer unparalleled insights about worker safety under various work conditions.
5. Maipl Therapeutics, Inc. Forms Strategic Alliance with Endosure, Inc. to Facilitate First-in-Human Trial of Novel Non-Hormonal Endometriosis Therapy 
   "By incorporating the ENDOSURE TEST into the MA‑4604 development program, we have the potential to recruit the right patients faster, monitor response in near‑real time, and ultimately bring a much‑needed, non‑hormonal option to millions of women suffering from this debilitating disease," said Dr. Yong Yue, Chief Executive Officer of Maipl Therapeutics, Inc.
6. Persist AI Launches Cloud Lab to Accelerate Pharmaceutical Formulation Development, Raises $12M Series A Funding
   The new platform allows pharmaceutical companies to develop formulations using Persist AI's state-of-the-art robotic laboratory facilities through a website, dramatically accelerating drug development timelines while using a fraction of the materials required by traditional methods.
7. More Americans Know Their Streaming Platform Passwords by Heart Than Their Cholesterol Score, New Survey Reveals
   Quest Diagnostics revealed the results of its second "Know Your Health" survey. Findings revealed that most Americans are eager to take an active role in their healthcare journey, but many experience barriers to receiving care, feel their doctors do not focus enough on preventive care and wellness discussions, and have gaps in knowledge on important personal health information.
8. Armata Pharmaceuticals Announces Positive Topline Data from the Phase 1b/2a diSArm Study of Intravenously Administered AP-SA02 in Complicated Staphylococcus aureus Bacteremia 
   "This trial and these data are what the field of phage therapy has been eagerly awaiting for over a decade and represent a critical leap forward for Armata and for the role of bacteriophages in combating life-threatening systemic infections," stated Dr. Deborah Birx, Chief Executive Officer of Armata.
9. BioMarin Strengthens Enzyme Therapy Business with Acquisition of Inozyme Pharma 
   The acquisition will strengthen BioMarin's enzyme therapies portfolio, adding a late-stage enzyme replacement therapy, INZ-701, which is currently being assessed for the treatment of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) Deficiency, a rare, serious and progressive genetic condition that affects blood vessels, soft tissues and bones.
10. U.S. FDA Approves BLA for Novavax's COVID-19 Vaccine 
    "This approval solidifies a pathway for Americans aged 65 and older and those aged 12 through 64 with an underlying condition that puts them at high risk for severe outcomes from COVID-19 to have access to a protein-based, non-mRNA COVID-19 vaccine," said John C. Jacobs, President and Chief Executive Officer, Novavax.
11. Michigan Medicine Joins Longitude Health as new Member 
    The addition of Michigan Medicine marks the first new member to join Longitude Health since its launch in October 2024. Michigan Medicine will play an integral role in shaping the continued development of Longitude Health's initial initiatives, including Longitude Rx (specialty pharmacy), Longitude PHM (population health), and Longitude FX (financial experience).
12. LGBTQ+ Patients Face Widespread Discomfort and Discrimination in Healthcare, New Study Finds 
    Over one-third of LGBTQ+ respondents (36%) admitted to lying to their doctor, compared to just 16% of straight respondents. The reasons? Fear of judgment, stigma, and assumptions from providers remain top barriers to honest conversations about health, especially around topics like sexual history, drug use, and mental health.
13. REGENXBIO Announces Strategic Royalty Monetization Agreement for Up to $250 Million 
    "This strategic financing brings future potential funds forward and extends our runway beyond multiple meaningful milestones, including the potential FDA approval of RGX-121 for MPS II, top-line data readout and BLA submission for RGX-202 for Duchenne, and top-line data readouts for two pivotal studies of subretinal ABBV-RGX-314 for wet AMD," said Mitchell Chan Chief Financial Officer of REGENXBIO.
14. Medtronic announces intent to separate Diabetes business 
    This strategic decision will create a more focused Medtronic, with a more simplified portfolio in high margin growth markets. At the same time, it will create an independent, scaled leader in Diabetes, focused on accelerating innovation and differentiated as the only company to commercialize a complete ecosystem to address intensive insulin management.

For more news like this, check out all of the latest health-related releases from PR Newswire.

Do you have a health press release to distribute? Sign up with PR Newswire to share your story with the audiences who matter most.

Helping Journalists Stay Up to Date on Industry News

These are just a few of the recent press releases that consumers and the media should know about. To be notified of releases relevant to their coverage area, journalists can set up a custom newsfeed with PR Newswire for Journalists.

Once they're signed up, reporters, bloggers, and freelancers have access to the following free features:

• Customization: Users can create customized newsfeeds that will deliver relevant news right to their inbox. Newsfeed results can be targeted by keywords, industry, subject, geography, and more.
• Photos and Videos: Thousands of multimedia assets are available to download and include in a journalist or blogger's next story.
• Subject Matter Experts: Journalists will have access to ProfNet, a database of industry experts to connect with as sources or for quotes in their articles.
• Related Resources: Our journalist- and blogger-focused blog, Beyond Bylines, features regular media news roundups, writing tips, upcoming events, and more.

About PR Newswire

PR Newswire is the industry's leading press release distribution partner with an unparalleled global reach of more than 440,000 newsrooms, websites, direct feeds, journalists and influencers and is available in more than 170 countries and 40 languages. From our award-winning Content Services offerings, integrated media newsroom and microsite products, Investor Relations suite of services, paid placement and social sharing tools, PR Newswire has a comprehensive catalog of solutions to solve the modern-day challenges PR and communications teams face. For 70 years, PR Newswire has been the preferred destination for brands to share their most important news stories across the world.

For questions, contact the team at [email protected].

SOURCE PR Newswire